EDMOND DE ROTHSCHILD HOLDING S.A. - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$5,0000.0%1,5000.0%0.00%
Q2 2016$5,0000.0%1,5000.0%0.00%
Q1 2016$5,000
-90.6%
1,500
-87.0%
0.00%
-100.0%
Q4 2015$53,000
-20.9%
11,500
+4.5%
0.00%
-50.0%
Q3 2015$67,000
-48.1%
11,000
-26.7%
0.00%
-33.3%
Q2 2015$129,00015,0000.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,250,000$1,975,0001.00%
Broadfin Capital, LLC 3,567,624$5,636,0000.24%
Abingworth LLP 437,994$679,0000.19%
GREAT POINT PARTNERS LLC 250,000$395,0000.19%
Rhenman & Partners Asset Management AB 400,000$632,0000.18%
BVF INC/IL 559,624$884,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$2,673,0000.10%
Perceptive Advisors 503,156$795,0000.07%
Gruss Capital Management LP 960,000$1,517,0000.04%
Spark Investment Management LLC 103,400$160,0000.03%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders